Johns Hopkins HIV Guide
Stavudine
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals (ARVs).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: May 1, 2017
Citation
Smith, Janessa, and Paul A Pham. "Stavudine." Johns Hopkins HIV Guide, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545194/5.1/Stavudine.
Smith J, Pham PA. Stavudine. Johns Hopkins HIV Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545194/5.1/Stavudine. Accessed June 3, 2023.
Smith, J., & Pham, P. A. (2017). Stavudine. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545194/5.1/Stavudine
Smith J, Pham PA. Stavudine [Internet]. In: Johns Hopkins HIV Guide. ; 2017. [cited 2023 June 03]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545194/5.1/Stavudine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Stavudine
ID - 545194
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/05/01/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545194/5.1/Stavudine
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
